Inhibrx Biosciences, Inc. INBX Lessee Operating Lease Liability Undiscounted Excess Amount
Lessee Operating Lease Liability Undiscounted Excess Amount at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s lessee operating lease liability undiscounted excess amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s lessee operating lease liability undiscounted excess amount?
- Inhibrx Biosciences, Inc. (INBX) reported lessee operating lease liability undiscounted excess amount of $681K in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s lessee operating lease liability undiscounted excess amount changed year-over-year?
- Inhibrx Biosciences, Inc.'s lessee operating lease liability undiscounted excess amount decreased by 50.6% year-over-year, from $1.38M to $681K.